Meeting
2016 ASCO Quality Care Symposium
A single institution’s experience with the value of FDG-PET-CT imaging in patients with newly diagnosed stage IIB-IIIB breast cancer.
Authors
Gary Schnur
Cleveland Clinic, Cleveland, OH
Gary Schnur, Katherine Glass, Chad W Cummings, Alberto J. Montero, Jame Abraham, Halle C. F. Moore, G. Thomas Budd
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Practice of Quality and Cost, Value, and Policy in Quality
Track
Cost, Value, and Policy in Quality,Practice of Quality,Science of Quality
Sub Track
Learning from Projects Done in a Health System
Citation
J Clin Oncol 34, 2016 (suppl 7S; abstr 123)
DOI
10.1200/jco.2016.34.7_suppl.123
Abstract #
123
Poster Bd #
L6
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Quality Care Symposium
The costs of breast cancer care: Patient-reported experiences and preferences for transparency.
First Author: Rachel Adams Greenup
Poster
2016 ASCO Annual Meeting
Risk of synchronous distant recurrence at time of local-regional recurrence in stage II and III breast cancer patients.
First Author: Heather B. Neuman
Poster
2014 Breast Cancer Symposium
Value of routine staging imaging studies (RSIS) for patients with stage III breast cancer (BC).
First Author: Caroline Irene Piatek
Poster
2024 ASCO Gastrointestinal Cancers Symposium
The economic impact of short-term imaging with metastatic pancreatic ductal adenocarcinoma.
First Author: Abbey Bayless